Patients voice enters drug pricing reform committee expanding for faster fairer outcomes

Published on 24 April 2026

What changes when patients sit on pricing decisions

A key committee reviewing India’s drug pricing reforms has been expanded to include patients, shifting the debate from numbers on paper to real healthcare impact. The move aims to make pricing decisions more grounded in affordability and access, potentially influencing how reforms are designed and implemented as stakeholders push for faster, fairer outcomes.

Drug pricing reforms committee has been expanded
Patient representation is now part of the decision process
Reforms may better reflect affordability and access realities
Committee changes could speed up how solutions are shaped

#patients #committee #health policy #pricing reforms #drug pricing

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Patients voice enters drug pricing reform committee expanding for faster fairer outcomes

The full experience is on mobile.